Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  5,723 results for ""Immunogenicity, Vaccine""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Vaccine Safety and Immunogenicity in Patients With Multiple Sclerosis Treated With Natalizumab.

  • Authors : Carvajal R; Department of Neurology-Neuroimmunology, Multiple Sclerosis Centre of Catalonia (Cemcat), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.; Zabalza A

Subjects: Multiple Sclerosis*/Multiple Sclerosis*/Multiple Sclerosis*/drug therapy ; Natalizumab*/Natalizumab*/Natalizumab*/administration & dosage ; Vaccines, Inactivated*/Vaccines, Inactivated*/Vaccines, Inactivated*/immunology

  • Source: JAMA network open [JAMA Netw Open] 2024 Apr 01; Vol. 7 (4), pp. e246345. Date of Electronic Publication: 2024 Apr 01.Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

A meta-analysis of immunogenicity and safety of two versus single-doses of influenza A (H1N1) vaccine in person living with HIV.

  • Authors : Zhang T; Department of Epidemiology and Health Statistics, College of Public Health, Zhengzhou University, Henan, People's Republic of China.; Geng J

Subjects: Immunogenicity, Vaccine* ; Influenza A Virus, H1N1 Subtype* ; Influenza Vaccines*/Influenza Vaccines*/Influenza Vaccines*/immunology

  • Source: International journal of STD & AIDS [Int J STD AIDS] 2024 Apr; Vol. 35 (5), pp. 326-336. Date of Electronic Publication: 2023 Dec 12.Publisher: Sage Country of Publication: England NLM ID: 9007917 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1758-1052

Record details

Read More Add to Saved list
×
Academic Journal

Reactogenicity and Peak Anti-RBD-S1 IgG Concentrations in Individuals with No Prior COVID-19 Infection Vaccinated with Different SARS-CoV-2 Vaccines.

  • Authors : Milevoj Kopcinovic L; Department of Clinical Chemistry, Sestre Milosrdnice University Hospital Center, Zagreb, Croatia.; Unic A

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/immunology ; Immunoglobulin G*

  • Source: Laboratory medicine [Lab Med] 2024 Mar 07; Vol. 55 (2), pp. 162-168.Publisher: Oxford University Press Country of Publication: England NLM ID: 0250641 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Long-term immunogenicity and safety of heterologous boosting with a SARS-CoV-2 mRNA vaccine (SYS6006) in Chinese participants who had received two or three doses of inactivated vaccine.

  • Authors : Huang J; Clinical Trial Center, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.; Qiu Y

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19 Vaccines* ; Immunogenicity, Vaccine*COVID-19 vaccine booster shot

  • Source: Journal of medical virology [J Med Virol] 2024 Mar; Vol. 96 (3), pp. e29542.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7705876 Publication Model: Print Cited Medium: Internet ISSN: 1096-9071

Record details

Read More Add to Saved list
×
Academic Journal

Evaluation of the serum levels of CCL2, CCL3, and IL-29 after first and second administrations of the COVID-19 vaccine (Oxford-AstraZeneca).

  • Authors : Bagheri-Hosseinabadi Z; Molecular Medicine Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran; Department of Clinical Biochemistry, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.

Subjects: ChAdOx1 nCoV-19*/ChAdOx1 nCoV-19*/ChAdOx1 nCoV-19*/administration & dosage ; ChAdOx1 nCoV-19*/ChAdOx1 nCoV-19*/ChAdOx1 nCoV-19*/immunology ; Chemokine CCL2*/Chemokine CCL2*/Chemokine CCL2*/blood

  • Source: Immunobiology [Immunobiology] 2024 Mar; Vol. 229 (2), pp. 152789. Date of Electronic Publication: 2024 Jan 28.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8002742 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

TLR4 Ligands in Typhoid Vi Polysaccharide Subunit Vaccines Contribute to Immunogenicity.

Subjects: Toll-Like Receptor 4* ; Typhoid Fever*/Typhoid Fever*/Typhoid Fever*/prevention & control ; Typhoid-Paratyphoid Vaccines*/Typhoid-Paratyphoid Vaccines*/Typhoid-Paratyphoid Vaccines*/immunology

  • Source: ImmunoHorizons [Immunohorizons] 2024 Jan 01; Vol. 8 (1), pp. 29-34.Publisher: American Association of Immunologists, Inc Country of Publication: United States NLM ID: 101708159 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Safety and immunogenicity of a 15-valent pneumococcal conjugate vaccine in Japanese healthy infants: A Phase I study (V114-028).

Subjects: Immunogenicity, Vaccine* ; Pneumococcal Infections*/Pneumococcal Infections*/Pneumococcal Infections*/prevention & control ; Pneumococcal Vaccines*/Pneumococcal Vaccines*/Pneumococcal Vaccines*/immunology

  • Source: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2023 Dec 31; Vol. 19 (1), pp. 2180973. Date of Electronic Publication: 2023 Mar 07.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Immunogenicity and Safety of a SARS-CoV-2 Inactivated Vaccine KCONVAC in Chinese Children: Randomized, Double-blind, Placebo-controlled Phase 1 and 2 Trials.

  • Authors : Liu J; From the Shenzhen Kangtai Biological Products Co., Ltd., Shenzhen, Guangdong, China.; Huang B

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Immunogenicity, Vaccine* ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/adverse effects

  • Source: The Pediatric infectious disease journal [Pediatr Infect Dis J] 2023 Dec 01; Vol. 42 (12), pp. 1136-1142. Date of Electronic Publication: 2023 Sep 04.Publisher: Williams & Wilkins Country of Publication: United States NLM ID: 8701858 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Safety and immunogenicity of the COVID-19 mRNA vaccine CS-2034: A randomized, double-blind, dose-exploration, placebo-controlled multicenter Phase I clinical trial in healthy Chinese adults.

  • Authors : Jin Z; Beijing Friendship Hospital, Capital Medical University, China.; Wu J

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/therapeutic use ; Immunogenicity, Vaccine*

  • Source: The Journal of infection [J Infect] 2023 Dec; Vol. 87 (6), pp. 556-570. Date of Electronic Publication: 2023 Oct 28.Publisher: W.B. Saunders Country of Publication: England NLM ID: 7908424 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Immunogenicity and Reactogenicity of Messenger RNA Coronavirus Disease 2019 Vaccine Booster Administered by Intradermal or Intramuscular Route in Thai Older Adults.

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/immunology ; Immunogenicity, Vaccine*COVID-19 vaccine booster shot

  • Source: The Journal of infectious diseases [J Infect Dis] 2023 Oct 03; Vol. 228 (7), pp. 868-877.Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  5,723 results for ""Immunogenicity, Vaccine""